Former OBIO CAAP company, ChipCare Corporation, a Toronto-based start-up company creating a point-of-care platform that will bring lifesaving diagnostics to millions without access, has expanded its team. With the addition of key assay development scientists and project management expertise, ChipCare has expanded the capacity of its existing team to commercialize its polyvalent diagnostic platform.
Click Here to Learn About the Team